AMPHENOL CORP /DE/
10-Q, 2000-05-01
ELECTRONIC CONNECTORS
Previous: CHARTER NATIONAL VARIABLE ANNUITY ACCOUNT, 485BPOS, 2000-05-01
Next: AMPHENOL CORP /DE/, S-3, 2000-05-01



<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                            ------------------------

                                   FORM 10-Q

<TABLE>
<C>        <S>
   /X/     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
           SECURITIES EXCHANGE ACT OF 1934
</TABLE>

                 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2000
                                       OR

<TABLE>
<C>        <S>
   / /     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
           SECURITIES EXCHANGE ACT OF 1934
</TABLE>

        FOR THE TRANSITION PERIOD FROM ______________ TO ______________

                         COMMISSION FILE NUMBER 1-10879

                            ------------------------

                              AMPHENOL CORPORATION

             (Exact name of Registrant as specified in its Charter)

<TABLE>
<S>                                            <C>
               DELAWARE                                     22-2785165
    (State or other jurisdiction of                      (I.R.S. Employer
    incorporation or organization)                     Identification No.)

                  358 HALL AVENUE, WALLINGFORD, CONNECTICUT 06492
                                   203-265-8900
                    (Address, including zip code, and telephone
                   number, including area code, of Registrant's
                           principal executive offices)
</TABLE>

                            ------------------------

    Indicate by check mark whether the Registrant (1) has filed reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes /X/  No / /

    As of April 28, 2000, the total number of shares outstanding of Class A
Common Stock was 41,451,572.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
                              AMPHENOL CORPORATION

                           INDEX TO QUARTERLY REPORT
                                  ON FORM 10-Q

<TABLE>
<CAPTION>
                                                                                        PAGE
                                                                                      --------
<S>                     <C>                                                           <C>
Part I                  Financial Information

    Item 1.             Financial Statements:

                        Condensed Consolidated Balance Sheet March 31, 2000 and
                          December 31, 1999.........................................      3

                        Condensed Consolidated Statement of Income Quarter ended
                          March 31, 2000 and 1999...................................      5

                        Condensed Consolidated Statement of Changes in Shareholders'
                          Deficit Quarter ended March 31, 2000......................      6

                        Condensed Consolidated Statement of Changes in Shareholders'
                          Deficit Quarter ended March 31, 1999......................      7

                        Condensed Consolidated Statement of Cash Flow Quarter ended
                          March 31, 2000 and 1999...................................      8

                        Notes to Condensed Consolidated Financial Statements........      9

    Item 2.             Management's Discussion and Analysis of Financial Condition
                          and Results of Operations.................................     11

    Item 3.             Quantitative and Qualitative Disclosures About Market
                          Risk......................................................     13

Part II                 Other Information

    Item 1.             Legal Proceedings...........................................     14

    Item 2.             Changes in Securities.......................................     14

    Item 3.             Defaults upon Senior Securities.............................     14

    Item 4.             Submission of Matters to a Vote of Security-Holders.........     14

    Item 5.             Other Information...........................................     14

    Item 6.             Exhibits and Reports on Form 8-K............................     14

Signatures..........................................................................     18
</TABLE>

                                       2
<PAGE>
                         PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                              AMPHENOL CORPORATION

                      CONDENSED CONSOLIDATED BALANCE SHEET

                             (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                                                               MARCH 31,    DECEMBER 31,
                                                                 2000           1999
                                                              -----------   ------------
                                                              (UNAUDITED)
<S>                                                           <C>           <C>
                        A S S E T S
Current Assets:
  Cash and short-term cash investments......................    $ 12,560      $ 12,898
  Accounts receivable, less allowance for doubtful accounts
    of $2,419 and $2,232, respectively......................     135,218       111,711
  Inventories...............................................     184,683       189,433
  Prepaid expenses and other assets.........................      20,599        21,137
                                                                --------      --------
Total current assets........................................     353,060       335,179
                                                                --------      --------
Land and depreciable assets, less accumulated depreciation
  of $213,645 and $206,923, respectively....................     129,552       119,950
Deferred debt issuance costs................................       9,709        10,267
Excess of cost over fair value of net assets acquired.......     388,832       360,999
Other assets................................................      13,566         9,981
                                                                --------      --------
                                                                $894,719      $836,376
                                                                ========      ========
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       3
<PAGE>
                              AMPHENOL CORPORATION

                      CONDENSED CONSOLIDATED BALANCE SHEET

                             (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                                                               MARCH 31,    DECEMBER 31,
                                                                 2000           1999
                                                              -----------   ------------
                                                              (UNAUDITED)
<S>                                                           <C>           <C>
           LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities:
  Accounts payable..........................................   $  81,696      $  71,495
  Accrued interest..........................................      12,671          9,779
  Other accrued expenses....................................      61,694         47,824
  Current portion of long-term debt.........................      16,741         16,829
                                                               ---------      ---------
Total current liabilities...................................     172,802        145,927
                                                               ---------      ---------
Long-term debt..............................................     751,218        745,658
Deferred taxes and other liabilities........................      27,174         25,957
Shareholders' Deficit:
  Common stock..............................................          21             21
  Additional paid-in deficit................................    (311,044)      (318,641)
  Accumulated earnings......................................     270,746        250,482
  Accumulated translation adjustment........................     (16,198)       (13,028)
                                                               ---------      ---------
Total shareholders' deficit.................................     (56,475)       (81,166)
                                                               ---------      ---------
                                                               $ 894,719      $ 836,376
                                                               =========      =========
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       4
<PAGE>
                              AMPHENOL CORPORATION

                   CONDENSED CONSOLIDATED STATEMENT OF INCOME

                                  (UNAUDITED)

                 (DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                                                THREE MONTHS ENDED
                                                                     MARCH 31,
                                                              -----------------------
                                                                 2000         1999
                                                              ----------   ----------
<S>                                                           <C>          <C>
Net sales...................................................  $  300,049   $  237,164
Costs and expenses:
  Cost of sales, excluding depreciation and amortization....     197,176      157,289
  Depreciation and amortization expense.....................       7,039        6,885
  Selling, general and administrative expense...............      41,873       34,262
  Amortization of goodwill..................................       3,275        3,078
                                                              ----------   ----------
Operating income............................................      50,686       35,650
Interest expense............................................     (15,843)     (19,812)
Other expenses, net.........................................      (1,904)      (1,233)
                                                              ----------   ----------
Income before income taxes..................................      32,939       14,605
Provision for income taxes..................................     (12,675)      (6,366)
                                                              ----------   ----------
Net income..................................................  $   20,264   $    8,239
                                                              ==========   ==========
Net income per common share--Basic..........................  $      .49   $      .23
                                                              ==========   ==========
  Average common shares outstanding--Basic..................  41,465,756   35,724,682
Net income per common share--Diluted........................  $      .48   $      .23
                                                              ==========   ==========
  Average common shares outstanding--Diluted................  42,580,344   36,062,650
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       5
<PAGE>
                              AMPHENOL CORPORATION

                  CONDENSED CONSOLIDATED STATEMENT OF CHANGES
                            IN SHAREHOLDERS' DEFICIT

                   FOR THE THREE MONTHS ENDED MARCH 31, 2000

                                  (UNAUDITED)
                             (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                                             ADDITIONAL                                              ACCUMULATED       TOTAL
                                   COMMON     PAID-IN           COMPREHENSIVE         ACCUMULATED    TRANSLATION   SHAREHOLDERS'
                                   STOCK      DEFICIT              INCOME               EARNINGS     ADJUSTMENT       DEFICIT
                                  --------   ----------   -------------------------   ------------   -----------   -------------
<S>                               <C>        <C>          <C>                         <C>            <C>           <C>
Beginning balance at
  December 31, 1999.............    $21      ($318,641)                                 $250,482      ($13,028)      ($81,166)
Comprehensive income:
  Net income....................                                         [$20,264]        20,264                       20,264
                                                          -------------------------
  Other comprehensive loss, net
    of tax:
    Foreign currency translation
      adjustment................                                           (3,170)                      (3,170)        (3,170)
                                                          -------------------------
Comprehensive income............                                         [$17,094]
                                                          =========================
Issuance of 226,414 shares of
  common stock related to
  acquistion....................                 7,500                                                                  7,500
Other adjustments...............                    97                                                                     97
                                    ---      ---------                                  --------      --------       --------
Ending balance at March 31, 2000    $21      ($311,044)                                 $270,746      ($16,198)      ($56,475)
                                    ===      =========                                  ========      ========       ========
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       6
<PAGE>
                              AMPHENOL CORPORATION

                  CONDENSED CONSOLIDATED STATEMENT OF CHANGES
                            IN SHAREHOLDERS' DEFICIT

                   FOR THE THREE MONTHS ENDED MARCH 31, 1999
                                  (UNAUDITED)
                             (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                                             ADDITIONAL                                             ACCUMULATED        TOTAL
                                   COMMON     PAID-IN          COMPREHENSIVE         ACCUMULATED    TRANSLATION    SHAREHOLDERS'
                                   STOCK      DEFICIT              INCOME              EARNINGS      ADJUSTMENT       DEFICIT
                                  --------   ----------   ------------------------   ------------   ------------   -------------
<S>                               <C>        <C>          <C>                        <C>            <C>            <C>
Beginning balance at
  December 31, 1998.............    $18      ($499,928)                                $214,861       ($ 7,208)      ($292,257)
Comprehensive income:
  Net income....................                                        [$8,239]          8,239                          8,239
                                                          ------------------------
    Other comprehensive loss,
      net of tax:
Foreign currency translation
  adjustment....................                                         (4,853)                        (4,853)         (4,853)
                                                          ------------------------
Comprehensive income............                                        [$3,386]
                                                          ========================
Other adjustments...............                    45                                                                      45
                                    ---      ---------                                 --------       --------       ---------
Ending balance at March 31, 1999    $18      ($499,883)                                $223,100       ($12,061)      ($288,826)
                                    ===      =========                                 ========       ========       =========
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       7
<PAGE>
                              AMPHENOL CORPORATION

                 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW

                                  (UNAUDITED)
                             (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                                                              THREE MONTHS ENDED
                                                                   MARCH 31,
                                                              -------------------
                                                                2000       1999
                                                              --------   --------
<S>                                                           <C>        <C>
Net income..................................................  $20,264    $ 8,239
Adjustments for cash from operations:
  Depreciation and amortization.............................   10,314      9,963
  Amortization of deferred debt issuance costs..............      558        691
  Net change in non-cash components of working capital         11,280     (6,365)
                                                              -------    -------
Cash flow provided by operations............................   42,416     12,528
                                                              -------    -------
Cash flow from investing activities:
  Capital additions, net....................................  (10,267)    (5,595)
  Investment in acquisitions................................  (33,565)    (1,416)
                                                              -------    -------
Cash flow used by investing activities......................  (43,832)    (7,011)
                                                              -------    -------
Cash flow from financing activities:
Net change in borrowings under revolving credit
  facilities................................................    1,078     (4,821)
                                                              -------    -------
Cash flow provided (used) by financing activities...........    1,078     (4,821)
                                                              -------    -------
Net change in cash and short-term cash investments               (338)       696
Cash and short-term cash investments balance, beginning of
  period                                                       12,898      3,095
                                                              -------    -------
Cash and short-term cash investments balance, end of period   $12,560    $ 3,791
                                                              =======    =======
Cash paid during the period for:
  Interest..................................................  $12,393    $14,058
  Income taxes paid (refunded), net.........................    5,940       (110)
</TABLE>

     See accompanying notes to condensed consolidated financial statements.

                                       8
<PAGE>
                              AMPHENOL CORPORATION

                        NOTES TO CONDENSED CONSOLIDATED
                              FINANCIAL STATEMENTS

                 (DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)

NOTE 1--PRINCIPLES OF CONSOLIDATION AND INTERIM FINANCIAL STATEMENTS

    The condensed consolidated balance sheet as of March 31, 2000 and December
31, 1999, and the related condensed consolidated statements of income and of
changes in shareholders' deficit and of cash flow for the three months ended
March 31, 2000 and 1999 include the accounts of the Company and its
subsidiaries. The interim financial statements included herein are unaudited. In
the opinion of management all adjustments, consisting only of normal recurring
adjustments, necessary for a fair presentation of such interim financial
statements have been included. The results of operations for the three months
ended March 31, 2000 are not necessarily indicative of the results to be
expected for the full year. These financial statements should be read in
conjunction with the financial statements and notes included in the Company's
1999 Annual Report on Form 10-K.

NOTE 2--INVENTORIES

Inventories consist of:

<TABLE>
<CAPTION>
                                                        MARCH 31,    DECEMBER 31,
                                                          2000           1999
                                                       -----------   ------------
                                                       (UNAUDITED)
<S>                                                    <C>           <C>
Raw materials and supplies...........................    $ 29,064      $ 28,022
Work in process......................................     115,333       115,231
Finished goods.......................................      40,286        46,180
                                                         --------      --------
                                                         $184,683      $189,433
                                                         ========      ========
</TABLE>

NOTE 3--REPORTABLE BUSINESS SEGMENTS (UNAUDITED)

    The Company has two reportable business segments: interconnect products and
assemblies and cable products. The interconnect products and assemblies segment
produces connectors and connector assemblies primarily for the communications,
aerospace, industrial and automotive markets. The cable products segment
produces coaxial and flat ribbon cable primarily for communication markets,
including cable television. The Company evaluates the performance of business
units on, among other things, profit or loss from operations before interest
expense, goodwill and other intangible amortization expense, headquarters'
expense allocations, income taxes and nonrecurring gains and losses. The
Company's reportable segments are an aggregation of business units that have
similar production processes and products. The segment results for the three
months ended March 31, 2000 and 1999 are as follows:

<TABLE>
<CAPTION>
                              INTERCONNECT PRODUCTS          CABLE
                                 AND ASSEMBLIES            PRODUCTS                TOTAL
                              ---------------------   -------------------   -------------------
                                2000        1999        2000       1999       2000       1999
                              ---------   ---------   --------   --------   --------   --------
<S>                           <C>         <C>         <C>        <C>        <C>        <C>
Net sales
  -- external...............  $225,347    $178,008    $74,702    $59,156    $300,049   $237,164
  -- intersegment...........        75         156      3,582      2,150       3,657      2,306
Segment operating income....    42,378      29,623     15,147     10,910      57,525     40,533
</TABLE>

                                       9
<PAGE>
                              AMPHENOL CORPORATION

                        NOTES TO CONDENSED CONSOLIDATED
                        FINANCIAL STATEMENTS (CONTINUED)

                 (DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)

NOTE 3--REPORTABLE BUSINESS SEGMENTS (UNAUDITED) (CONTINUED)
Reconciliation of segment operating income to consolidated income before taxes
for the three months ended March 31, 2000 and 1999:

<TABLE>
<CAPTION>
                                                              2000       1999
                                                            --------   --------
<S>                                                         <C>        <C>
Segment operating income..................................  $57,525    $40,533
Amortization of goodwill..................................   (3,275)    (3,078)
Interest expense..........................................  (15,843)   (19,812)
Headquarters' expense and other net expenses..............   (5,468)    (3,038)
                                                            -------    -------
Consolidated income before income taxes...................  $32,939    $14,605
                                                            =======    =======
</TABLE>

NOTE 4--COMMITMENTS AND CONTINGENCIES

    In the course of pursuing its normal business activities, the Company is
involved in various legal proceedings and claims. Management does not expect
that amounts, if any, which may be required to be paid by reason of such
proceedings or claims will have a material effect on the Company's financial
condition or results of operations.

    Subsequent to the acquisition of Amphenol from Allied Signal Corporation
("Allied") in 1987, Amphenol and Allied have been named jointly and severally
liable as potentially responsible parties in relation to several environmental
cleanup sites. Amphenol and Allied have jointly consented to perform certain
investigations and remedial and monitoring activities at two sites and they have
been jointly ordered to perform work at another site. The responsibility for
costs incurred relating to these sites is apportioned between Amphenol and
Allied based on an agreement entered into in connection with the acquisition.
For sites covered by this agreement, to the extent that conditions or
circumstances occurred or existed at the time of or prior to the acquisition,
Allied is currently obligated to pay 80% of the costs up to $30,000 and 100% of
the costs in excess of $30,000. Management does not believe that the costs
associated with resolution of these or any other environmental matters will have
a material adverse effect on the Company's financial condition or results of
operations.

    A subsidiary of the Company has an agreement with a financial institution
whereby the subsidiary can sell an undivided interest of up to $60,000 in a
designated pool of qualified accounts receivable. The agreement expires in
May 2004. Under the terms of the agreement, new receivables are added to the
pool as collections reduce previously sold accounts receivable. The Company
services, administers and collects the receivables on behalf of the purchaser.
Fees payable to the purchaser under this agreement are equivalent to rates
afforded high quality commercial paper issuers plus certain administrative
expenses and are included in other expenses, net, in the accompanying Condensed
Consolidated Statement of Income. The agreement contains certain covenants and
provides for various events of termination. In certain circumstances the Company
is contingently liable for the collection of the receivables sold; management
believes that its allowance for doubtful accounts is adequate to absorb the
expense of any such liability. At March 31, 2000 and December 31, 1999,
approximately $60,000 in receivables were sold under the agreement and are
therefore not reflected in the accounts receivable balance in the accompanying
Condensed Consolidated Balance Sheet at those dates.

NOTE 5--STOCK SPLIT

    On March 14, 2000, the Board of Directors approved a two-for-one split of
the Company's common stock to be paid to shareholders of record as of March 23,
2000. On April 24, 2000, the Company's shareholders approved an increase in the
number of authorized shares from 40,000,000 to 100,000,000. On April 24, 2000,
each shareholder received one additional share of common stock for each share of
stock then held. All share and per-share amounts in the financial statements and
footnotes have been restated to reflect the split.

                                       10
<PAGE>
                      MANAGEMENT'S DISCUSSION AND ANALYSIS
                OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                 (DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)

ITEM 2.  RESULTS OF OPERATIONS

QUARTER ENDED MARCH 31, 2000 COMPARED WITH QUARTER ENDED MARCH 31, 1999

    Net sales increased approximately 27% to $300,049 in the first quarter of
2000 compared to sales of $237,164 for the same period in 1999. The increase is
primarily attributable to increased sales of interconnect products and cable
products for communication markets. In addition, sales of interconnect products
for aerospace and industrial applications increased in the first quarter of 2000
compared to the same period in 1999. Currency translation had the effect of
decreasing sales in the first quarter of 2000 by approximately $6.4 million when
compared to exchange rates for the 1999 period.

    The gross profit margin as a percentage of net sales (including depreciation
in cost of sales) was 32% for the first quarter of 2000 compared to 31% for the
1999 period. The increase in the gross profit margin is generally attributable
to changes in product mix.

    Selling, general and administrative expenses as a percentage of net sales
remained constant at approximately 14% for the first quarter of 2000 compared to
the 1999 period.

    Interest expense for the first quarter of 2000 was $15,843 compared to
$19,812 for the 1999 period. The decrease is primarily attributable to lower
average debt levels.

    The provision for income taxes for the first quarter of 2000 was at an
effective rate of 38% compared to 44% in the 1999 period. The decrease is
generally attributable to non-deductible expenses (goodwill amortization) being
a lower percentage of pretax income. The effective rate excluding non-deductible
goodwill amortization for the first quarter of 2000 was 35% compared to 36% in
the 1999 period.

LIQUIDITY AND CAPITAL RESOURCES

    Cash provided by operating activities was $42,416 in the first quarter of
2000 compared to $12,528 in the 1999 period. The increase in cash flow relates
primarily to an increase in net income adjusted for depreciation and
amortization charges and to a net decrease in non-cash components of working
capital.

    For the first quarter of 2000, cash from operating activities and borrowings
under the credit facility were used to fund capital expenditures of $10,267. In
addition, the Company acquired two companies that manufacture components for
mobile handsets and one company that manufactures highly engineered cable
assemblies for automotive applications. The total amount paid for these
acquisitions was $32.7 million in cash and 226,414 shares of common stock. These
acquisitions contributed $8.0 million in sales in the first quarter of 2000, and
the effect on net income was not material. In the 1999 period, cash from
operating activities was used to fund capital expenditures of $5,595, fund
acquisitions of $1,416 and to repay indebtedness of $4,821.

    In conjunction with the Merger and Recapitalization in 1997, the Company
entered into a $900 million bank agreement comprised of a $150 million revolving
credit facility that expires in the year 2004 and a $750 million term loan
facility. The term loan facility, as modified, included a $350 million Tranche A
maturing over a 7 year period ending 2004, and a $375 million Tranche B with
required amortization in 2005 and 2006. The bank agreement is secured by pledges
of 100% of the capital stock of the Company's direct domestic subsidiaries and
65% of the capital stock of direct material foreign subsidiaries, requires the
maintenance of certain interest coverage and leverage ratios, and includes
limitations with respect to, among other things, indebtedness and restricted
payments,

                                       11
<PAGE>
including dividends on the Company's common stock. At March 31, 2000 there were
$599.5 million of borrowings outstanding under the term loan facility.
Availability under the revolving credit facility at March 31, 2000 was
$136.5 million, after reduction of $5.3 million for outstanding letters of
credit.

    The Company has entered into interest rate swap agreements that effectively
fix the Company's interest cost on $450 million of borrowings under the bank
agreement to the extent that LIBOR interest rates remain below 7% for
$300 million of borrowings and below 8% for $150 million of borrowings.

    The Company's EBITDA as defined in the bank agreement was $61.5 million and
$46.9 million for the three months ended March 31, 2000 and 1999, respectively.
EBITDA is not a defined term under Generally Accepted Accounting Principles
(GAAP) and is not an alternative to operating income or cash flow from
operations as determined under GAAP. The Company believes that EBITDA provides
additional information for determining its ability to meet future debt service
requirements; however, EBITDA does not reflect cash available to fund cash
requirements.

    The Company's primary ongoing cash requirements will be for debt service,
capital expenditures and product development activities. The Company's debt
service requirements consist primarily of principal and interest on bank
borrowings and interest on its 9 7/8% Senior Subordinated Notes due 2007.

    The Company has not paid, and does not have any present intention to
commence payment of, cash dividends on its common stock. The Company expects
that ongoing requirements for debt service, capital expenditures and product
development activities will be funded by internally-generated cash flow and
availability under the Company's revolving credit facility. The Company may also
use cash to fund part or all of the cost of future acquisitions.

ENVIRONMENTAL MATTERS

    Subsequent to the acquisition of Amphenol Corporation in 1987, Amphenol and
Allied have been named jointly and severally liable as potentially responsible
parties in relation to several environmental cleanup sites. Amphenol and Allied
have jointly consented to perform certain investigations and remedial and
monitoring activities at two sites and they have been jointly ordered to perform
work at another site. The responsibility for costs incurred relating to these
sites is apportioned between Amphenol and Allied based on an agreement entered
into in connection with the acquisition. For sites covered by this agreement, to
the extent that conditions or circumstances occurred or existed at the time of
or prior to the acquisition, Allied is currently obligated to pay 80% of the
costs up to $30 million and 100% of the costs in excess of $30 million.
Management does not believe that the costs associated with resolution of these
or any other environmental matters will have a material adverse effect on the
Company's financial condition or results of operations.

RECENT ACCOUNTING CHANGE

    In June 1998 the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 133 (FAS 133), "Accounting for Derivative
Instruments and Hedging Activities." This statement requires that an entity
recognize all derivatives as either assets or liabilities in the Statement of
Financial Position and measure those instruments at fair value. The accounting
for changes in the fair value of a derivative (that is, gains and losses)
depends on the intended use of the derivative and its resulting designation. The
Company is in the process of evaluating the effect this new standard will have
on the Company's financial statements. The Company is required to adopt
FAS 133, as amended by FAS 137, beginning January 1, 2001.

                                       12
<PAGE>
EURO CURRENCY CONVERSION

    On January 1, 1999, certain member countries of the European Union
established fixed conversion rates between their existing currencies and the
European Union's common currency (the "euro"). The transition period for the
introduction of the euro began on January 1, 1999. Beginning January 1, 2002,
the participating countries will issue new euro-denominated bills and coins for
use in cash transactions. No later than July 1, 2002, the participating
countries will withdraw all bills and coins denominated in the legacy
currencies, so that the legacy currencies will no longer be legal tender for any
transactions, making the conversion to the euro complete.

    The Company is addressing the issues involved with the introduction of the
euro. Based on progress to date, the Company believes that the use of the euro
will not have a significant impact on the manner in which it conducts its
business. Accordingly, conversion to the euro is not expected to have a material
effect on the Company's consolidated financial position, consolidated results of
operations, or liquidity.

SAFE HARBOR STATEMENT

    Statements in this report that are not strictly historical are
"forward-looking" statements which should be considered as subject to the many
uncertainties that exist in the Company's operations and business environment.
These uncertainties which include, among other things, economic and currency
conditions, market demand and pricing and competitive and cost factors are set
forth in the Company's 1999 Annual Report on Form 10-K.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

    There has been no material change in the Company's assessment of its
sensitivity to market risk since its presentation set forth, in Item 7A.
"Quantitative and Qualitative Disclosures About Market Risk," in its 1999 Annual
Report on Form 10-K.

                                       13
<PAGE>
                                    PART II
                               OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

    Reference is made to the Company's 1999 Annual Report on Form 10-K, (the
"10-K").

ITEM 2. CHANGES IN SECURITIES

    None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

    None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS

    During the first quarter of 2000, written consents of the holders of the
Company's Class A Common Stock were solicited to approve an amendment to the
Company's Amended and Restated Certificate of Incorporation to increase the
number of shares of Class A Common Stock which the Company has authority to
issue by 60,000,000, from 40,000,000 to 100,000,000. The amendment was approved
in April 2000, with 17,238,990 consents submitted for the amendment, 219,646
consents submitted against the amendment and there were no abstaining consents.

ITEM 5. OTHER INFORMATION

    None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

    (a) Listing of Exhibits

<TABLE>
<C>   <S>
2.1   Agreement and Plan of Merger dated as of January 23, 1997
      between NXS Acquisition Corp. and Amphenol Corporation
      (incorporated by reference to Current Report on Form 8-K
      dated January 23, 1997).**

2.2   Amendment, dated as of April 9, 1997, to the Agreement and
      Plan of Merger between NXS Acquisition Corp. and Amphenol
      Corporation, dated as of January 23, 1997 (incorporated by
      reference to the Registration Statement on Form S-4
      (registration No. 333-25195) filed on April 15, 1997).**

3.1   Certificate of Merger, dated May 19, 1997 (including
      Restated Certificate of Incorporation of Amphenol
      Corporation)(filed as Exhibit 3.1 to the June 30, 1997
      10-Q).**

3.2   By-Laws of the Company as of May 19, 1997--NXS Acquisition
      Corp. By-Laws (filed as Exhibit 3.2 to the June 30, 1997
      10-Q).**

3.3   Amended and Restated Certificate of Incorporation, dated
      April 24, 2000 (filed as Exhibit 3.1 to the April 28, 2000
      Form 8-K).**

4.1   Indenture between Amphenol Corporation and IBJ Schroeder
      Bank and Trust Company, as Trustee, dated as of May 19,
      1997, relating to Senior Subordinated Notes due 2007 (filed
      as Exhibit 4.1 to the June 30, 1997 10-Q).**
</TABLE>

- ------------------------

*   Filed herewith

**  Previously filed

                                       14
<PAGE>

<TABLE>
<C>     <S>
 10.1   Amended and Restated Receivables Purchase Agreement dated as
        of May 19, 1997 among Amphenol Funding Corp., the Company,
        Pooled Accounts Receivable Capital Corporation and Nesbitt
        Burns Securities, Inc., as Agent (filed as Exhibit 10.1 to
        the June 30, 1997 10-Q).**

 10.2   Amended and Restated Purchase and Sale Agreement dated as of
        May 19, 1997 among the Originators named therein, Amphenol
        Funding Corp. and the Company (filed as Exhibit 10.2 to the
        June 30, 1997 10-Q).**

 10.3   Credit Agreement dated as of May 19, 1997 among the Company,
        Amphenol Holding UK, Limited, Amphenol Commercial and
        Industrial UK, Limited, the Lenders listed therein, The
        Chase Manhattan Bank, as Syndication Agent, the Bank of New
        York, as Documentation Agent and Bankers Trust Company, as
        Administrative Agent and Collateral Agent (filed as
        Exhibit 10.3 to the June 30, 1997 10-Q).**

 10.4   1998 Amphenol Incentive Plan (filed as Exhibit 10.5 to the
        December 31, 1997 10-K).**

 10.5   1999 Amphenol Incentive Plan (filed as Exhibit 10.6 to the
        December 31, 1998 10-K).**

 10.6   2000 Amphenol Incentive Plan (filed as Exhibit 10.6 to the
        December 31, 1999 10-K).**

 10.7   Pension Plan for Employees of Amphenol Corporation as
        amended and restated effective December 31, 1997 (filed as
        Exhibit 10.7 to the December 31, 1998 10-K).**

 10.8   First amendment to the Pension Plan for Employees of
        Amphenol Corporation dated October 1, 1998 (filed as
        Exhibit 10.8 to the December 31, 1998 10-K).**

 10.9   Second amendment to the Pension Plan for Employees of
        Amphenol Corporation dated February 4, 1999 (filed as
        Exhibit 10.9 to the December 31, 1998 10-K).**

10.10   Amphenol Corporation Supplemental Employee Retirement Plan
        formally adopted effective January 25, 1996 (filed as
        Exhibit 10.18 to the 1996 10-K).**

10.11   LPL Technologies Inc. and Affiliated Companies Employee
        Savings/401(k) Plan, dated and adopted January 23, 1990
        (filed as Exhibit 10.19 to the 1991 Registration
        Statement).**

10.12   Management Agreement between the Company and Dr. Martin H.
        Loeffler, dated July 28, 1987 (filed as Exhibit 10.7 to the
        1987 Registration Statement).**

10.13   Amphenol Corporation Directors' Deferred Compensation Plan
        (filed as Exhibit 10.11 to the December 31, 1997 10-K).**

10.14   Agreement and Plan of Merger among Amphenol Acquisition
        Corporation, Allied Corporation and the Company, dated
        April 1, 1987, and the Amendment thereto dated as of
        May 15, 1987 (filed as Exhibit 2 to the 1987 Registration
        Statement).**
</TABLE>

- ------------------------

*   Filed herewith

**  Previously filed

                                       15
<PAGE>

<TABLE>
<C>     <S>
10.15   Settlement Agreement among Allied Signal Inc., the Company
        and LPL Investment Group, Inc. dated November 28, 1988
        (filed as Exhibit 10.20 to the 1991 Registration
        Statement).**

10.16   Registration Rights Agreement dated as of May 19, 1997,
        among NXS Acquisition Corp., KKR 1996 Fund L.P., NXS
        Associates L.P., KKR Partners II, L.P. and NXS I, L.L.C.
        (filed as Exhibit 99.5 to Schedule 13D, Amendment No. 1,
        relating to the beneficial ownership of shares of the
        Company's Common Stock by NXS I, L.L.C., KKR 1996 Fund,
        L.P., KKR Associates (1996) L.P., KKR 1996 GP LLC, KKR
        Partners II, L.P., KKR Associates L.P., NXS Associates L.P.,
        KKR Associates (NXS) L.P., and KKR-NXS L.L.C. dated May 27,
        1997).**

10.17   Management Stockholders' Agreement entered into as of
        May 19, 1997 between the Company and Martin H. Loeffler
        (filed as Exhibit 10.13 to the June 30, 1997 10-Q).**

10.18   Management Stockholders' Agreement entered into as of
        May 19, 1997 between the Company and Edward G. Jepsen (filed
        as Exhibit 10.14 to the June 30, 1997 10-Q.)**

10.19   Management Stockholders' Agreement entered into as of
        May 19, 1997 between the Company and Timothy F. Cohane
        (filed as Exhibit 10.15 to the June 30, 1997 10-Q).**

10.20   1997 Option Plan for Key Employees of Amphenol and
        Subsidiaries (filed as Exhibit 10.16 to the June 30, 1997
        10-Q).**

10.21   Amended 1997 Option Plan for Key Employees of Amphenol and
        Subsidiaries (filed as Exhibit 10.19 to the June 30, 1998
        10-Q).**

10.22   Non-Qualified Stock Option Agreement between the Company and
        Martin H. Loeffler dated as of May 19, 1997 (filed as
        Exhibit 10.17 to the June 30, 1997 10-Q).**

10.23   Non-Qualified Stock Option Agreement between the Company and
        Edward G. Jepsen dated as of May 19, 1997 (filed as
        Exhibit 10.18 to the June 30, 1997 10-Q).**

10.24   Non-Qualified Stock Option Agreement between the Company and
        Timothy F. Cohane dated as of May 19, 1997 (filed as
        Exhibit 10.19 to the June 30, 1997 10-Q).**

10.25   First Amendment to Amended and Restated Receivables Purchase
        Agreement dated as of September 26, 1997 (filed as
        Exhibit 10.20 to the September 30, 1997 10-Q).**

10.26   Canadian Purchase and Sale Agreement dated as of
        September 26, 1997 among Amphenol Canada Corp., Amphenol
        Funding Corp. and Amphenol Corporation, individually and as
        the initial servicer (filed as Exhibit 10.21 to the
        September 30, 1997 10-Q).**
</TABLE>

- ------------------------

*   Filed herewith

**  Previously filed

                                       16
<PAGE>

<TABLE>
<C>     <S>
10.27   Amended and Restated Credit Agreement dated as of October 3,
        1997 among the Company, Amphenol Holding UK, Limited,
        Amphenol Commercial and Industrial UK, Limited, the Lenders
        listed therein, The Chase Manhattan Bank, as Syndication
        Agent, the Bank of New York, as Documentation Agent and
        Bankers Trust Company, as Administrative Agent and
        Collateral Agent (filed as Exhibit 10.22 to the
        September 30, 1997 10-Q).**

10.28   First Amendment dated as of May 1, 1998 to the Amended and
        Restated Credit Agreement dated as of October 3, 1997 among
        the Company, Amphenol Holding UK, Limited, Amphenol
        Commercial and Industrial UK, Limited, the Lenders listed
        therein, The Chase Manhattan Bank, as Syndication Agent, the
        Bank of New York, as Documentation Agent and Bankers Trust
        Company, as Administrative Agent and Collateral Agent (filed
        as Exhibit 10.25 to the March 31, 1998 10-Q).**

   27   Financial Data Schedule.*
</TABLE>

    (b) Reports filed on Form 8-K

      There were no reports on Form 8-K filed for or during the first quarter
      ended March 31, 2000. On April 28, 2000, the Company filed a report on
      Form 8-K including a copy of the Company's Amended and Restated
      Certificate of Incorporation filed with the State of Delaware on
      April 24, 2000 increasing the number of shares that the Company is
      authorized to issue from 40 million to 100 million shares of Class A
      Common Stock, par value $.001.

- ------------------------

*   Filed herewith

**  Previously filed

                                       17
<PAGE>
                                   SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

<TABLE>
<S>                                                    <C>  <C>
                                                       AMPHENOL CORPORATION

DATE: MAY 1, 2000                                      /s/ EDWARD G. JEPSEN
                                                       ---------------------------------------------
                                                       Edward G. Jepsen
                                                       EXECUTIVE VICE PRESIDENT AND
                                                       CHIEF FINANCIAL OFFICER
</TABLE>

                                       18

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0000820313
<NAME> AMPHENOL CORPORATION
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           12560
<SECURITIES>                                         0
<RECEIVABLES>                                   137637
<ALLOWANCES>                                    (2419)
<INVENTORY>                                     184683
<CURRENT-ASSETS>                                353060
<PP&E>                                          343197
<DEPRECIATION>                                (213645)
<TOTAL-ASSETS>                                  894719
<CURRENT-LIABILITIES>                           172802
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            21
<OTHER-SE>                                     (56496)
<TOTAL-LIABILITY-AND-EQUITY>                    894719
<SALES>                                         300049
<TOTAL-REVENUES>                                300049
<CGS>                                           197176
<TOTAL-COSTS>                                   197176
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (15843)
<INCOME-PRETAX>                                  32939
<INCOME-TAX>                                     12675
<INCOME-CONTINUING>                              20264
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     20264
<EPS-BASIC>                                        .49
<EPS-DILUTED>                                      .48


</TABLE>

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0000820313
<NAME> AMPHENOL CORPORATION
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                            3791
<SECURITIES>                                         0
<RECEIVABLES>                                    99109
<ALLOWANCES>                                    (1957)
<INVENTORY>                                     184995
<CURRENT-ASSETS>                                303479
<PP&E>                                          313010
<DEPRECIATION>                                (189651)
<TOTAL-ASSETS>                                  821030
<CURRENT-LIABILITIES>                           138914
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            18
<OTHER-SE>                                    (288844)
<TOTAL-LIABILITY-AND-EQUITY>                    821030
<SALES>                                         237164
<TOTAL-REVENUES>                                237164
<CGS>                                           157289
<TOTAL-COSTS>                                   157289
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (19812)
<INCOME-PRETAX>                                  14605
<INCOME-TAX>                                      6366
<INCOME-CONTINUING>                               8239
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      8239
<EPS-BASIC>                                        .23
<EPS-DILUTED>                                      .23


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission